BXRX

Baudax Bio, Inc. Common Stock
BXRX

Overview Fund Activity
Delisted

BXRX was delisted on the 15th of November, 2023.

Back to rankings

19 hedge funds and large institutions have $2.2M invested in Baudax Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-9
Holders Change %
-32.14%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
8
Reduced
2
Closed
16
Calls
$80K
Puts
–
Net Calls
+$80K
Net Calls Change
+$46K

Top Buyers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
$814K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
$416K
3
Renaissance Technologies
Renaissance Technologies
New York
$420K
4
Geode Capital Management
Geode Capital Management
Massachusetts
$105K
5
WAM
Warberg Asset Management
Illinois
$61K

Top Sellers

1
AC
Armistice Capital
New York
$0
2
GCP
GSA Capital Partners
United Kingdom
$0
3
State Street
State Street
Massachusetts
$0
4
AWA
Amplius Wealth Advisors
Pennsylvania
$0
5
UBS Group
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CBB
26
Citizens Business Bank
California
– -$5K -16 Closed
ASN
27
Advisory Services Network
Georgia
– -$3K -11 Closed
SIP
28
Stoneridge Investment Partners
Pennsylvania
– -$3K -11 Closed
Victory Capital Management
29
Victory Capital Management
Texas
– -$3K -9 Closed
CA
30
CoreCap Advisors
Michigan
– -$1K – –
1
2